Katja C Weisel Selected Research

Katja C Weisel Research Topics

Disease

35	Multiple Myeloma 05/2024 - 01/2009
3	Neoplasms (Cancer) 07/2021 - 05/2014
2	Septic Shock (Toxic Shock Syndrome) 02/2024 - 11/2022
2	Residual Neoplasm 09/2023 - 11/2022
2	Paraproteinemias (Monoclonal Gammopathy) 01/2023 - 07/2021
2	Renal Insufficiency (Renal Failure) 11/2022 - 06/2012
2	Hematologic Neoplasms (Hematological Malignancy) 07/2021 - 05/2013
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 03/2010 - 11/2008
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 02/2024
1	Meningoencephalitis 02/2024
1	Pneumonia (Pneumonitis) 02/2024
1	Pulmonary Embolism 02/2024
1	Sepsis (Septicemia) 02/2024
1	Colitis 02/2024
1	Chromothripsis 01/2024
1	Infections 12/2023
1	Heart Arrest (Cardiac Arrest) 11/2022
1	Enteritis 11/2022
1	COVID-19 11/2021
1	Pain (Aches) 01/2021
1	Lymphoma (Lymphomas) 01/2021
1	Diarrhea 01/2020
1	Fatigue 01/2020
1	Hyponatremia 01/2020
1	Nausea 01/2020
1	Neutropenia 01/2020
1	Thrombocytopenia (Thrombopenia) 01/2020
1	Vomiting 01/2020
1	Weight Loss (Weight Reduction) 01/2020
1	Disease Progression 01/2020
1	Leukocytosis (Pleocytosis) 05/2014
1	Sarcoma (Soft Tissue Sarcoma) 05/2014
1	Measles 06/2012
1	Acute Kidney Injury (Acute Renal Failure) 05/2012
1	Bone Diseases (Bone Disease) 01/2012
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2009
1	Immunoglobulin Light-chain Amyloidosis 01/2009
1	Cholangitis 01/2009
1	T-Cell Lymphoma (Lymphoma, T Cell) 11/2008
1	B-Cell Lymphoma (Lymphoma, B Cell) 11/2008

Drug/Important Bio-Agent (IBA)

19	Dexamethasone (Maxidex)FDA LinkGeneric 02/2024 - 06/2012
11	Lenalidomide (CC 5013)FDA Link 02/2024 - 01/2009
10	Bortezomib (Velcade)FDA Link 02/2024 - 08/2012
10	pomalidomideIBA 01/2019 - 02/2015
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2020
3	isatuximabIBA 09/2023 - 01/2022
3	Melphalan (Alkeran)FDA LinkGeneric 11/2022 - 01/2009
2	Monoclonal AntibodiesIBA 02/2024 - 11/2022
2	carfilzomibIBA 09/2023 - 01/2022
2	daratumumabIBA 09/2023 - 01/2021
2	CreatinineIBA 01/2023 - 06/2012
2	ixazomibIBA 07/2021 - 11/2020
2	selinexorIBA 01/2020 - 01/2019
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019 - 03/2010
2	fludarabineIBA 03/2010 - 11/2008
2	Alemtuzumab (Campath)FDA Link 03/2010 - 11/2008
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 05/2024
1	PENTAIBA 03/2024
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 03/2024
1	elotuzumabIBA 02/2024
1	Adenosine Monophosphate (AMP)IBA 01/2024
1	COVID-19 VaccinesIBA 11/2021
1	VaccinesIBA 07/2021
1	Neurokinin-1 Receptor AntagonistsIBA 01/2020
1	bismuth subsalicylate (Pepto-bismol)FDA LinkGeneric 01/2020
1	Olanzapine (Zyprexa)FDA Link 01/2020
1	Exportin 1 ProteinIBA 01/2020
1	CannabinoidsIBA 01/2020
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 01/2020
1	Loperamide (Imodium)FDA LinkGeneric 01/2020
1	MegestrolIBA 01/2020
1	Methylphenidate (Ritalin)FDA LinkGeneric 01/2020
1	SodiumIBA 01/2020
1	Thrombopoietin ReceptorsIBA 01/2020
1	Serotonin 5-HT3 Receptor AntagonistsIBA 01/2020
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2014
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 06/2012
1	Immunoglobulin G (IgG)IBA 06/2012
1	OsteoprotegerinIBA 01/2012
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2010
1	LigandsIBA 03/2009
1	Congo RedIBA 01/2009
1	Prednisone (Sone)FDA LinkGeneric 01/2009
1	AntibodiesIBA 11/2008

Therapy/Procedure

12	Therapeutics 02/2024 - 11/2008
5	Stem Cell Transplantation 02/2024 - 01/2021
3	Drug Therapy (Chemotherapy) 05/2014 - 01/2009
1	Transplantation 11/2022
1	Platelet Transfusion (Blood Platelet Transfusions) 01/2020
1	Renal Dialysis (Hemodialysis) 05/2012
1	Aftercare (After-Treatment) 11/2008